Grupo Espanol Multidisciplinario del Cancer Digestivo   Report issue

Academic/Hospital Phase 2
Founded: Madrid Spain (2006)

Organization Overview

First Clinical Trial
2007
NCT00789763
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Grupo Español Multidisciplinario de Cáncer Digestivo | Grupo Espanol Multidisciplinario del Cancer Digestivo

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Anus Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Colorectal Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 1)

Rectal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 17
  • # of Trial APIs: 19